Lenalidomide

Lenalidomide

Paramètre Spécifications
Nom du produit Lenalidomide
Numéro CAS 191732-72-6
Formule moléculaire C13H13N3O3
Poids moléculaire 259.26 g/mol
Apparence Poudre cristalline blanche à blanc cassé
Essai (HPLC) ≥99.5%
Solubilité Sparingly soluble in DMSO, methanol; practically insoluble in water
Colis 25 kg fiber drum with double polyethylene bags

Besoin d'aide ? Contacter notre équipe

Lenalidomide Structure

Synonymes : Lenalidomide, 191732-72-6, Revlimid, CC-5013, 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione

Lenalidomide is a synthetic immunomodulatory imide drug (IMiD) and a potent analog of thalidomide. It is manufactured as a white to off-white crystalline powder with high purity, typically ≥99.5% by HPLC, and is supplied as a generic active pharmaceutical ingredient (API) for oncology and hematology applications. As a second-generation IMiD, it offers improved potency and a more favorable safety profile compared to its parent compound.

In the pharmaceutical industry, Lenalidomide is primarily used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Its dual mechanism of action—direct tumor cell apoptosis and modulation of the immune system—makes it a valuable component in combination therapies. The API is available in bulk quantities to support generic drug development and commercial production.

Product Highlights

  • High Purity: ≥99.5% assay by HPLC, with strict control of organic impurities.
  • Regulatory Support: Compliant with ICH guidelines; CEP and DMF available upon request.
  • Reliable Supply: Consistent manufacturing scale to meet commercial demand.
  • Documentation: Full set of COA, MSDS, and TDS provided with each shipment.
  • Quality Assurance: Produced in cGMP-certified facilities.

Applications & Formulation Use

  • Treatment of multiple myeloma (in combination with dexamethasone).
  • Management of myelodysplastic syndromes (MDS) with deletion 5q abnormality.
  • Mantle cell lymphoma after relapse or progression.
  • Research on immunomodulatory and anti-angiogenic pathways.

Quality Specifications (QC Tests)

Test Item Spécifications
Identification IR, HPLC retention time conforms to reference standard
Perte au séchage ≤ 0,51 TP3T
Résidu au feu ≤ 0,11 TP3T
Métaux lourds ≤ 20 ppm
Organic Impurities Meet EP/USP requirements
Limites microbiologiques Total aerobic count ≤1000 CFU/g; Yeast & Mold ≤100 CFU/g

Bulk Supply & Ordering

  • Emballage: 25 kg fiber drum with double polyethylene bags, or as per customer request.
  • Quantité minimale de commande: 1 kg for trial orders; 25 kg for commercial orders.
  • Délai de livraison: 3-5 business days for stock items.
  • Documentation: COA, MSDS, TDS, and regulatory support (CEP/DMF) available.

Foire aux questions

What is the minimum order quantity (MOQ) for Lenalidomide?

Our MOQ is 1 kg for trial orders and 25 kg for commercial orders. For larger quantities, please contact us for a customized quote.

What is the delivery time?

For stock items, delivery is 3-5 business days after order confirmation. We ship globally via express or air freight.

Do you provide a Certificate of Analysis (COA) and samples?

Yes, a COA is provided with every shipment. Samples are available upon request for quality evaluation.

Contact & Ordering Information

  • Company: LyvBio Co., Ltd.
  • Address: Room 5-0203, Courtyard 205, Lianhu District, Xi’an, Shaanxi, China
  • Email: info@lyvbio.com
  • Phone: +86-29-65816888

send us your specification for a quotation.

RESTEZ EN CONTACT

Demande de devis

Notre adresse

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×